Shijiazhuang Yiling Pharmaceutical | Sustainability Performance

https://www.yilingpharm.com/

Develops, manufactures, and distributes pharmaceutical products. Activities include R&D, production, and marketing of medicines, focusing on therapeutic treatments and compliance with quality standards.

1992

China

10,001+ employees

Pharmaceuticals

$1B - 10B in revenue

$100M - 500M in profitability

Submit or report inaccurate data Download Company Insights

Sustainability Ranking & Industry Benchmark

#10025

Overall

#576

in China

#245

in Pharmaceuticals

Sustainability Maturity

Sustainability Intent

Available in
Scale package

Access

Beyond Top 100

Overview

Environmental

Energy consumptionWater managementAir and land impactNature and biodiversityNature riskClimate risk

Social

Diversity and inclusionPay gapsExternalities

Governance

TargetsSDG ImpactESG scores and exclusionsB-corp & CDP

Financial Data

Business performanceCapital & innovationAnalyst projections

View similiar companies

BioKangtai

China, Hospital & Health Care, Biotechnology

Shandong Buchang Pharmaceuticals

China, Hospital & Health Care, Pharmaceuticals

INT Medical Instruments

China, Hospital & Health Care, Medical Device

Renewable energy

90% 2023

Female engagement

34% 2024

Critical

Externalities

614.7K $, 2025

Aligned

Market cap

184.0B $, 2026▼8.8% YoY

Revenue

1.1B $, 2025▲16.8% YoY

R&D intensity

9.17% 2025

Controversy level

Very Low

Low

Noticeable

High

Severe

Download Controversy Analysis

Shijiazhuang Yiling Pharmaceutical Co Ltd, Chinese TCM (Traditional Chinese Medicine) major (Lianhua Qingwen capsules), has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate disclosure of TCM product quality including the contested 20202023 'Lianhua Qingwen' COVID19 marketing claims under Chinese SAMR investigation, plus periodic class actions over alleged inadequate disclosure affecting Chinese institutional shareholders.

Biodiversity impact

Reveal data for 2 credits

KPI	Metric	Year
		2021	2022	2023	2024	2025	Benchmark
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	-	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******

KPI	Metric	Year
	2019	2020	2021	2022	2023	Benchmark
*******	*******	-	-	-	*******	*******	*******

Water management

Reveal data for 2 credits

KPI	Metric	Year
		2019	2020	2021	2022	2023	Benchmark
*******	*******	-	-	-	*******	*******	*******
*******	*******	-	-	-	*******	*******	*******
*******	*******	-	-	-	*******	*******	*******

Air pollution

Reveal data for 2 credits

KPI	Metric	Year
		2019	2020	2021	2022	2023	Benchmark
*******	*******	-	-	-	*******	*******	*******
*******	*******	-	-	-	*******	*******	*******
*******	*******	-	-	-	*******	*******	*******

Land use

Reveal data for 2 credits

KPI	Metric	Year
		2021	2022	2023	2024	2025	Benchmark
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******

Diversity & inclusion

Reveal data for 3 credits

KPI	Metric	Year
		2020	2021	2022	2023	2024	Benchmark
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******

Pay gap breakdown

Reveal data for 1 credit

KPI	Metric	Year
		2020	2021	2022	2023	2024	Benchmark
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	-	-	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	-	-	*******	*******	*******
*******	*******	-	-	*******	*******	*******	*******
*******	*******	-	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	-	-	*******	*******	*******	*******

Externalities

Reveal data for 1 credit

KPI	Metric	Year
		2021	2022	2023	2024	2025	Benchmark
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******

SDG impact (historical)

Reveal data for 5 credits

KPI	Metric	Year
		2020	2021	2022	2023	2024	Benchmark
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******

Reporting

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees

Available in
Scale package

Access

Controversy level

Very Low

Low

Noticeable

High

Severe

Download Controversy Analysis

Shijiazhuang Yiling Pharmaceutical Co Ltd, Chinese TCM (Traditional Chinese Medicine) major (Lianhua Qingwen capsules), has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate disclosure of TCM product quality including the contested 20202023 'Lianhua Qingwen' COVID19 marketing claims under Chinese SAMR investigation, plus periodic class actions over alleged inadequate disclosure affecting Chinese institutional shareholders.

Shijiazhuang Yiling Pharmaceutical | Sustainability Performance

Sustainability Ranking & Industry Benchmark

Sustainability Maturity

Sustainability Intent

Available in Scale package

View similiar companies

Renewable energy

Renewable electricity

Female engagement

Controversy level

Climate risk

Nature risk

Production loss

Revenue at risk

Assets exposed to sensitive locations

Biodiversity loss in km²

Biodiversity loss in CO2e

Potential species loss

Biodiversity impact

Waste management

Water management

Air pollution

Land use

Diversity & inclusion

Pay gap breakdown

Externalities

Revenue & EBITDA

Margin trends

R&D intensity

Return on invested capital

Analyst revenue estimates & actuals

Environmental policy coverage

Overall score

Environment

Social

Governance

Exclusion screening

CDP Scores

SDG impact

SDG impact (historical)

Reporting

Sustainability employees

Available in Scale package

Shijiazhuang Yiling Pharmaceutical | Sustainability Performance

Sustainability Ranking & Industry Benchmark

Sustainability Maturity

Sustainability Intent

Available in Scale package

View similiar companies

Renewable energy

Renewable electricity

Female engagement

Controversy level

Climate risk

Nature risk

Production loss

Revenue at risk

Assets exposed to sensitive locations

Biodiversity loss in km²

Biodiversity loss in CO2e

Potential species loss

Biodiversity impact

Waste management

Water management

Air pollution

Land use

Diversity & inclusion

Pay gap breakdown

Externalities

Revenue & EBITDA

Margin trends

R&D intensity

Return on invested capital

Analyst revenue estimates & actuals

Environmental policy coverage

Overall score

Environment

Social

Governance

Exclusion screening

Available in
Scale package

Available in
Scale package

Available in
Scale package

Available in
Scale package